Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Sarepta Therapeutics
SRPT
$1.76B
| $786K | ﹤0.01% |
8,500
-119,478
| -93% | -$9.2M |
|
|
YQ
2677
17 Education & Technology Group
YQ
$19.5M
| $786K | ﹤0.01% |
+43,665
| New | +$1.3M |
|
|
AHG
2678
Akso Health Group
AHG
$1.2B
| $785K | ﹤0.01% |
350,598
+24,014
| +7% | +$40K |
|
2679
Noodles & Co
NDLS
$104M
| $785K | ﹤0.01% |
+8,315
| New | +$813K |
|
|
PRO
2680
DELISTED
PROS Holdings
PRO
| $784K | ﹤0.01% |
+22,100
| New | +$928K |
|
2681
Cass Information Systems
CASS
$748M
| $781K | ﹤0.01% |
18,659
-45,726
| -71% | -$1.95M |
|
|
VERO
2682
DELISTED
Venus Concept
VERO
| $778K | ﹤0.01% |
1,878
-693
| -27% | -$272K |
|
|
ATC
2683
DELISTED
Atotech Limited
ATC
| $777K | ﹤0.01% |
32,191
-129,467
| -80% | -$3.11M |
|
2684
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $776K | ﹤0.01% |
+20,400
| New | +$800K |
|
2685
Ranger Energy Services
RNGR
$378M
| $771K | ﹤0.01% |
83,789
-13,401
| -14% | -$111K |
|
|
ELSE
2686
DELISTED
Electro-Sensors
ELSE
| $768K | ﹤0.01% |
152,700
-9,200
| -6% | -$46.2K |
|
2687
iShares Expanded Tech Sector ETF
IGM
$10.7B
| $767K | ﹤0.01% |
11,400
-9,000
| -44% | -$626K |
|
2688
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$1.99B
| $766K | ﹤0.01% |
+36,300
| New | +$770K |
|
2689
iShares Russell 3000 ETF
IWV
$20.2B
| $765K | ﹤0.01% |
+3,000
| New | +$785K |
|
|
LOAN
2690
Manhattan Bridge Capital
LOAN
$47.1M
| $765K | ﹤0.01% |
112,528
-32,163
| -22% | -$208K |
|
|
SNCR
2691
DELISTED
Synchronoss Technologies
SNCR
| $765K | ﹤0.01% |
35,414
-59,081
| -63% | -$1.45M |
|
2692
Stereotaxis
STXS
$137M
| $764K | ﹤0.01% |
+142,100
| New | +$1.07M |
|
2693
Lesaka Technologies
LSAK
$413M
| $763K | ﹤0.01% |
164,079
-34,100
| -17% | -$149K |
|
|
PLAN
2694
DELISTED
Anaplan, Inc.
PLAN
| $761K | ﹤0.01% |
12,500
-553,400
| -98% | -$32.9M |
|
2695
Vanguard Financials ETF
VFH
$13.7B
| $760K | ﹤0.01% |
8,200
+2,900
| +55% | +$268K |
|
2696
Virco
VIRC
$94.8M
| $759K | ﹤0.01% |
221,266
-22,602
| -9% | -$79.9K |
|
|
OSG
2697
Octave Specialty Group
OSG
$257M
| $756K | ﹤0.01% |
+52,800
| New | +$754K |
|
2698
Xtant Medical Holdings
XTNT
$60.3M
| $756K | ﹤0.01% |
680,800
-331,200
| -33% | -$431K |
|
2699
IDEAYA Biosciences
IDYA
$3.5B
| $755K | ﹤0.01% |
29,600
-39,000
| -57% | -$911K |
|
2700
Perspective Therapeutics
CATX
$338M
| $753K | ﹤0.01% |
119,363
-138,667
| -54% | -$945K |
|
Similar funds
Renaissance Technologies's Q3 2021 Portfolio in Review
As of Q3 2021, Renaissance Technologies held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Renaissance Technologies's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Renaissance Technologies added most to Nike in Q3 2021, an estimated $453M increase.
- Renaissance Technologies's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Renaissance Technologies fully exited Amazon in Q3 2021, selling an estimated $897M.
- Renaissance Technologies's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Renaissance Technologies opened 663 new positions and closed 653 in Q3 2021.
- Renaissance Technologies's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.